Intco Medical Technology Co., Ltd. Class A 300677

INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders rose 17.86% to RMB 837.3 million (approx. US$124.6 million). Adjusted net profit attributable to shareholders, excluding nonrecurring gains and losses, climbed 165.00% to RMB 1.06 billion (approx. US$157.7 million).

INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has been included in S&P Global's Sustainability Yearbook (China Edition) 2025 and recognized as an Industry Mover for its ESG progress, reflecting the Company's continued progress in environmental, social and governance (ESG) performance.

INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, outlining progress in emissions reduction, clean energy adoption, product innovation, quality management, corporate governance and social responsibility as the Company advances its long-term sustainability strategy.

As global markets grapple with rising inflation and geopolitical uncertainties, Asian equities present intriguing opportunities for investors seeking value. In this environment, identifying stocks that are trading significantly below their intrinsic value can be particularly appealing, offering potential for growth when market conditions stabilize.

As Asian markets navigate rising energy costs and inflationary pressures, investors are increasingly on the lookout for stocks that offer potential value amidst economic uncertainties. In this context, identifying undervalued stocks can be a strategic move, as these equities may present opportunities for growth when market conditions stabilize.

Amid rising inflation pressures and geopolitical uncertainties, Asian markets have shown mixed performance, with some indices declining while others remain resilient. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to navigate the current economic landscape. A good stock in these conditions often exhibits strong fundamentals and resilience against external pressures, making it an attractive...

As global markets experience varied reactions to economic data and geopolitical developments, Asian equities have shown resilience, with Chinese and Japanese indices posting gains amid positive domestic demand and AI-driven optimism. In this environment, identifying undervalued stocks requires a focus on companies that demonstrate strong fundamentals and potential for growth despite broader market uncertainties.

As Asian markets experience a resurgence, driven by resilient domestic demand and optimism surrounding geopolitical developments, investors are increasingly focused on identifying opportunities that may be undervalued in this evolving landscape. In such a climate, stocks that demonstrate strong fundamentals and potential for growth despite being priced below their estimated value can present compelling opportunities for discerning investors.

As Asian markets experience a resurgence, with Chinese equities advancing and Japanese indices reaching record highs, investors are increasingly turning their attention to value opportunities within the region. In this context, identifying stocks priced below their intrinsic estimates becomes crucial for those looking to capitalize on potential growth amid current market dynamics.

INTCO Medical ("INTCO" or "the Company"), a leading global manufacturer of disposable gloves, reported its 2025 annual results, with revenue reaching RMB 9.93 billion (approximately US$1.46 billion), up 4.23% year over year and marking a four-year high.